The global IgA nephropathy market is anticipated to witness steady growth from 2025 to 2035, driven by the growing incidence of chronic kidney diseases and the introduction of innovative, disease-modifying therapies. The market size is expected to increase from USD 46.82 billion in 2025 to USD 99.66 billion by 2035, expanding at a CAGR of …
Continue reading “IgA Nephropathy Market to Reach USD 99.66 Bn by 2035, Growing at 7.6% CAGR”